<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04051138</url>
  </required_header>
  <id_info>
    <org_study_id>Voxx1</org_study_id>
    <nct_id>NCT04051138</nct_id>
  </id_info>
  <brief_title>The Effect of VOXX/eSmartr High Performance Technology on Sports Vision Ability</brief_title>
  <official_title>The Effect of VOXX/eSmartr High Performance Technology on Sports Vision Ability</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ChampionsEdge, LLC</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>ChampionsEdge, LLC</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed to compare the effect of Voxx/eSmartr technology on common measures of&#xD;
      sports vision performance including (Hand-Eye Coordination/Reaction time, visual&#xD;
      concentration and basic visual functions of size detection and contrast sensitivity). The&#xD;
      study will be a randomized, prospective, double-blind design in order to determine the effect&#xD;
      of this technology on a subject's sports vision ability.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 15, 2019</start_date>
  <completion_date type="Actual">October 30, 2019</completion_date>
  <primary_completion_date type="Actual">October 30, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>randomized, double blind, prospective</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>CoreScore</measure>
    <time_frame>1 day</time_frame>
    <description>A measure of visual function scored on a linear scale fro +5 to -5, more positive scores are better</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hand-Eye Coordination/Reaction Time</measure>
    <time_frame>1 day</time_frame>
    <description>A measure of how fast the subject reacts to a visual target with their hand, scored on milliseconds, faster the better</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neurotracker score</measure>
    <time_frame>1 day</time_frame>
    <description>A measure of how correctly the subject can track multiple objects, scored from 0 to 5 with higher score being better</description>
  </secondary_outcome>
  <enrollment type="Actual">50</enrollment>
  <condition>Vision, Binocular</condition>
  <condition>Sports Medicine</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Voxx socks and sleeves</intervention_name>
    <description>participants will be tested with a true device as well as with a placebo device</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria.&#xD;
&#xD;
          -  Female or Male age 18-45 years of age&#xD;
&#xD;
          -  Exercises at least once a week by self-report&#xD;
&#xD;
          -  Physically able to complete the HEC/RT test (e.g. no shoulder or arm discomfort or&#xD;
             limitation&#xD;
&#xD;
        Exclusion Criteria.&#xD;
&#xD;
          -  Member of a vulnerable population&#xD;
&#xD;
          -  Visual or physical condition which precludes performing the physical or visual testing&#xD;
             (e.g. strabismus, double vision, shoulder or arm pain or injury)&#xD;
&#xD;
          -  Previous training in hand-eye coordination/reaction time or visual concentration&#xD;
&#xD;
          -  History of double vision or strabismus&#xD;
&#xD;
          -  Insufficient vision to drive an automobile in NY State&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daniel M Laby, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>ChampionsEdge, LLC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>SportsVisionNYC</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10019</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>August 5, 2019</study_first_submitted>
  <study_first_submitted_qc>August 7, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 9, 2019</study_first_posted>
  <last_update_submitted>January 25, 2021</last_update_submitted>
  <last_update_submitted_qc>January 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

